[The use of leukomax for potentiating combined chemotherapy of small cell lung cancer].
Gorbunova
V A
VA
Bychkov
M B
MB
Perevodchikova
N I
NI
Orel
N F
NF
Smirnova
N B
NB
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Ispol'zovanie leĭkomaksa s tsel'iu intensifikatsii kombinirovannoĭ khimioterapii melkokletochnogo raka lëgkogo.